Prevalence of Pertussis Antibodies in Maternal Blood, Cord Serum, and Infants From Mothers With and Those Without Tdap Booster Vaccination During Pregnancy in Argentina
Author(s) -
Aurelia Fallo,
Silvieyro,
G. Malles,
Claudia Lara,
Daniela Hozbor,
Jonathan Zintgraff,
Silvina Mazzeo,
Héctor E. Davison,
Susana González,
Estella Zapulla,
Oscar Canle,
Miguel Huespe,
Marcelo Galas,
Eduardo López
Publication year - 2016
Publication title -
journal of the pediatric infectious diseases society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.269
H-Index - 31
eISSN - 2048-7207
pISSN - 2048-7193
DOI - 10.1093/jpids/piw069
Subject(s) - medicine , pregnancy , vaccination , cord blood , booster (rocketry) , pediatrics , whooping cough , antibody , umbilical cord , tetanus , obstetrics , immunology , genetics , biology , physics , astronomy
Morbidity and mortality rates for pertussis in infants are high because disease often occurs before the onset of routine immunization or in those who do not complete a primary immunization series. Pertussis immunization is recommended during pregnancy to achieve antibody levels sufficient to protect young infants. To our knowledge, no previous reports of maternal pertussis immunization results in Latin America exist in the literature.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom